Clinical risk assessment and portfolio triage
InClinico is a platform form Data-driven multimodal forecast of single clinical trial's probability of success (PoS). InClinico utilizes massive amounts of data about the targets, diseases, clinical trials, and even scientists involved with the study at the preclinical and clinical stages.
Predict clinical trials success rate
Recognize the weak points in trial design
Adopt the best practices in the industry
Buy-side analysts at pharma-focused funds
BD&L executives at pharma companies
Clinical researchers & developers
Technical due diligence for Mergers and Acquisitions, licensing and partnership
Pharmaceutical portfolio de-risking
Competitive analysis
Search for the assets to invest in
Investment portfolio de-risking
AI-augmented trial design - endpoints, sites, eligibility
Research on general red flags
Post-mortem analysis on failed projects for possible revival
Proprietary ML algorithms for information extraction & data harmonization
Comprehensively harmonized public data with targeted bridges of manually curated datasets
Advanced NLP system with a feedback loop from the annotation experts
Large preclinical data feed from CROs
Comprehensive and uniform data
- score the clinical trial that you are planning

- find out which clinical trial protocol features influence the probability of success the most in therapeutic area

- highlight important parts of the clinical trial protocol that affect probability of sucess

- optimize your clinical trial protocol to improve the probability of success
inClinico for the clinical trial design:
- find the pharma company and its pharmaceutical assets

- assess the risk of the companies development pipeline

- estimate the NPV more precisely

- compare the pharmaceutical asset with competitor programs
inClinico for the due diligence on pharmaceutical development pipeline:
Data Source
  • 5M OMICs data samples
    A full spectrum of transcriptomics, genomics, epigenomics, proteomics, single cell data
    generated by the scientific community
  • 30M Publications
    Published biomedical research results
  • 3M Grants
    Life sciences research grant funding
  • 3.8M Patents
    Patents covering the life sciences industry.
  • 342K Clinical Trials
    Explore extra knowledge related to the clinical trials design
  • 13K Drugs
    Drugs from Phase 1 of clinical trial
    till Launched phase
Prospective inClinico validation